Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 14;19(20):13280.
doi: 10.3390/ijerph192013280.

New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review

Affiliations

New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review

Marysia Wrona et al. Int J Environ Res Public Health. .

Abstract

As the population recovers from the coronavirus disease 2019 (COVID-19) pandemic, a subset of individuals is emerging as post-coronavirus disease (post-COVID) patients who experience multifactorial long-term symptoms several weeks after the initial recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this systematic review is to present the latest scientific reports that evaluate changes in glucose levels, blood pressure readings and lipid profiles after recovery from COVID-19 to verify the hypothesis that new-onset diabetes mellitus, arterial hypertension and dyslipidaemia are a possible sequela of a COVID-19 infection. The open access databases PubMed and Google Scholar were searched. Articles investigating patients with residual clinical signs and biochemical alteration indicating diabetes, hypertension and dyslipidaemia at least a month after recovering from COVID-19 were included. It has been shown that a select number of patients were diagnosed with new-onset diabetes, arterial hypertension and dyslipidaemia after COVID-19 infection. Alterations in glucose levels, blood pressure and lipid profiles months after initial infection shows the importance of considering diabetes mellitus, arterial hypertension and dyslipidaemia as part of the multifactorial diagnostic criteria post-COVID to better provide evidence-based clinical care.

Keywords: COVID-19 sequelae; long-COVID; new-onset diabetes mellitus; new-onset dyslipidaemia; new-onset hypertension; post-COVID.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Centers for Disease Control and Prevention Post-COVID Conditions. Centers for Disease Control and Prevention. Retrieved 10 March 2022. [(accessed on 16 September 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
    1. Pavli A., Theodoridou M., Maltezou H.C. Post-COVID syndrome: Incidence, clinical spectrum and challenges for primary healthcare professionals. Arch. Med. Res. 2021;52:575–581. doi: 10.1016/j.arcmed.2021.03.010. - DOI - PMC - PubMed
    1. Vehar S., Boushra M., Ntiamoah P., Biehl M. Post-Acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-Haulers. Clevel. Clin. J. Med. 2021;88:267–272. doi: 10.3949/ccjm.88a.21010. - DOI - PubMed
    1. NHS Long-Term Effects of Coronavirus (Long COVID). NHS Choices. [(accessed on 10 March 2022)]. Available online: https://www.nhs.uk/conditions/coronavirus-COVID-19/long-Term-Effects-of-....
    1. World Health Organisation. (n.d.) Coronavirus Disease (COVID-19): Post COVID-19 Condition. World Health Organisation. [(accessed on 10 March 2022)]. Available online: https://www.who.int/news-room/questions-and-answers/item/coronavirus-dis....

Publication types